首页> 外国专利> PHARMACEUTICAL COMPOSITION COMPRISING A PROBIOTIC AND PREBIOTIC TO PREVENT ACQUISITION OF OR TREAT DRUG RESISTANT INFECTIONS

PHARMACEUTICAL COMPOSITION COMPRISING A PROBIOTIC AND PREBIOTIC TO PREVENT ACQUISITION OF OR TREAT DRUG RESISTANT INFECTIONS

机译:药物组合物,包括预防性和抗药性感染的益生性和益生性

摘要

The present invention provides a pharmaceutical composition comprising a probiotic and a prebiotic for preventing acquisition of and/or alleviating symptoms associated with an infection caused by an Extended-spectrum beta-lactamases (ESBL) producing organism and other drug resistant pathogens. More particularly, the pharmaceutical composition comprises at least one Lactillobacillus specie(s) as a probiotic and at least one oligosaccharide as a prebiotic. The present invention further provides a method of preventing acquisition of and/or treating an infection caused by Extended-spectrum beta-lactamases (ESBL) producing bacteria and other drug resistant pathogens, comprising administering an effective amount of a pharmaceutical composition comprising a probiotic and a prebiotic to a subject in need thereof.
机译:本发明提供了包含益生菌和益生元的药物组合物,用于预防获得和/或减轻与产生超广谱β-内酰胺酶(ESBL)的生物和其他抗药性病原体引起的感染相关的症状。更特别地,药物组合物包含至少一种作为益生菌的乳杆菌属物种和至少一种作为益生菌的寡糖。本发明进一步提供了一种预防和/或治疗由产生超广谱β-内酰胺酶(ESBL)的细菌和其他抗药性病原体引起的感染的方法,该方法包括给予有效量的包含益生菌和抗微生物剂的药物组合物。益生元给有需要的受试者。

著录项

  • 公开/公告号US2020246401A1

    专利类型

  • 公开/公告日2020-08-06

    原文格式PDF

  • 申请/专利权人 ASIAN INSTITUTE OF PUBLIC HEALTH;

    申请/专利号US201816652058

  • 发明设计人 PRAVAS RANJAN MISRA;

    申请日2018-10-04

  • 分类号A61K35/747;A61K31/702;

  • 国家 US

  • 入库时间 2022-08-21 11:21:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号